Tokyo, Japan

Atsushi Fukuzaki

This inventor holds 1 USPTO granted patent. Top assignee: Tokyo Tanabe Company, Ltd.. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Atsushi Fukuzaki. Retrieved from https://idiyas.com/inventor/atsushi-fukuzaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Atsushi Fukuzaki: Innovator in Indoline Compounds

Introduction

Atsushi Fukuzaki is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly with his work on indoline compounds. His innovative approach has led to the development of a unique compound that has potential applications in medical treatments.

Latest Patents

Atsushi Fukuzaki holds a patent for an indoline compound and a 5-HT₃ receptor antagonist containing the same. This patent represents a significant advancement in the understanding and treatment of conditions related to serotonin receptors.

Career Highlights

Fukuzaki is currently employed at Tokyo Tanabe Company, Ltd., where he continues to push the boundaries of pharmaceutical research. His work has been instrumental in developing new therapeutic options for patients.

Collaborations

He has collaborated with esteemed colleagues such as Shinji Tsuchiya and Nobuyuki Yasuda, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Atsushi Fukuzaki's contributions to the field of pharmaceuticals through his patent on indoline compounds highlight his role as a key innovator in the industry. His ongoing work promises to lead to further advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…